Replies to post #454185 on Anavex Life Sciences Corp (AVXL)

[frrol]

Statistical analysis of trial data is indeed complex. It is not "like a mining expedition" for biotechs, but the opposite. It is a scientific endeavor adhering to a statistical assessment plan using pre-defined endpoint measures.

Ironically, this is what the complaint is alleging we did not do. That is, it alleges the company deviated from plan, to the detriment of the investing public. The question is whether Missling was careful, just sloppy, or data mining and thereby misled public investors. The latter is alleged, and would be illegal. It's now a legal matter.

[kund]

Statistical analysis of biotech trials is very complex.

only when one want to do post-hoc analysis to fit the narrative. Clown CEO is above his head with those super responder, he designed flawed trials using tiny phase2a and claiming drug can cure anything on planet earth.

What happen to provisional approval by TGA? is Australia ready with infrastructure to support first trillion dollar company?

[Investor2014]

Cut'n'paste MB artists doesn't add any knowledge to the field.